In addition, inhibitory receptors on the T-cell surface such as PD-1, LAG-3 and TIM-3 may bind to ligands that are expressed by tumour cells and actively impair T-cell responses [38,39,40]. This evidence concerns the gene HAVCR2 and neoplasm.